How many 8-K filings has Bridgebio Oncology Therapeutics, Inc. filed?

Bridgebio Oncology Therapeutics, Inc. (BBOT) has 10 8-K (Current Event Report) filings on record, spanning Feb 2024 to Mar 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Bridgebio Oncology Therapeutics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Bridgebio Oncology Therapeutics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Bridgebio Oncology Therapeutics, Inc. (BBOT) — 8-K Filings

All 8-K filings from Bridgebio Oncology Therapeutics, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

BridgeBio Oncology Appoints New CMO, Dr. Morrissey — Mar 26, 2026 Risk: medium
BridgeBio Oncology Therapeutics, Inc. announced on March 24, 2026, the departure of Dr. Jonathan B. Lim from his role as Chief Medical Officer. The company also
BridgeBio Oncology Therapeutics Reports Material Events — Aug 13, 2025 Risk: medium
BridgeBio Oncology Therapeutics, Inc. (formerly Helix Acquisition Corp. II) filed an 8-K on August 13, 2025, reporting several material events as of August 12,
Helix Acquisition Corp. II Files 8-K — Aug 6, 2025 Risk: low
Helix Acquisition Corp. II filed an 8-K on August 6, 2025, disclosing information related to Regulation FD and financial statements. The company, incorporated i
Helix Acquisition Corp. II Files 8-K on Security Holder Vote — Aug 4, 2025 Risk: low
Helix Acquisition Corp. II filed an 8-K on August 4, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details
Helix Acquisition Corp. II Files 8-K — Jul 11, 2025 Risk: low
Helix Acquisition Corp. II filed an 8-K on July 11, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the com
Helix Acquisition Corp. II Files 8-K — Mar 3, 2025 Risk: low
On February 28, 2025, Helix Acquisition Corp. II entered into a material definitive agreement. The company also reported on unregistered sales of equity securit
Helix Acquisition Corp. II Files 8-K — Feb 28, 2025 Risk: low
Helix Acquisition Corp. II filed an 8-K on February 28, 2025, reporting information related to Regulation FD Disclosure and Financial Statements and Exhibits. T
Helix Acquisition Corp. II Files 8-K on Director/Officer Changes — Feb 10, 2025 Risk: low
Helix Acquisition Corp. II filed an 8-K on February 10, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and c
Helix Acquisition Corp. II Files 8-K on Feb 13 Event — Feb 20, 2024 Risk: medium
Helix Acquisition Corp. II filed an 8-K on February 20, 2024, reporting an event that occurred on February 13, 2024. The filing indicates that the company, a bl
Helix Acquisition Corp. II Reports Material Agreement, Equity Sales, Officer Changes — Feb 14, 2024 Risk: medium
Helix Acquisition Corp. II filed an 8-K on February 14, 2024, detailing events from February 8, 2024. The filing reported the company's entry into a material de

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX